Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Propylthiouracil MeSH Descriptor Data 2026


MeSH Heading
Propylthiouracil
Tree Number(s)
D03.383.742.698.875.842.708
Unique ID
D011441
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D011441
Annotation
a thyroid antag
Scope Note
A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534)
Entry Term(s)
6-Propyl-2-Thiouracil
Pharm Action
Antimetabolites
Antithyroid Agents
Registry Numbers
721M9407IY
Related Numbers
51-52-5
CAS Type 1 Name
4(1H)-Pyrimidinone, 2,3-dihydro-6-propyl-2-thioxo-
Date Introduced
1966/01/01
Last Updated
2016/05/31
Propylthiouracil Preferred
page delivered in 0.143s